Concepedia

An Vandebosch

AV

25

Publications

4K

Citations

20

H-Index

2004

Active since

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

Janssen (Netherlands)

University of Maryland, Baltimore

Fred Hutch Cancer Center

An Vandebosch is an author at Janssen (Belgium) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2004–2024

25

Publications

25

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Jerald Sadoff, Glenda Gray, An Vandebosch et al. · New England Journal of Medicine · 2021 · 2.5K citations · Full text

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

Jerald Sadoff, Glenda Gray, An Vandebosch et al. · New England Journal of Medicine · 2022 · 246 citations · Full text

Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin

Damayanthi Devineni, Linda Morrow, Marcus Hompesch et al. · Diabetes Obesity and Metabolism · 2012 · 221 citations

Correlation Between Type of Adaptive Immune Response Against Porcine Circovirus Type 2 and Level of Virus Replication

Peter Meerts, Steven Van Gucht, Eric Cox et al. · Viral Immunology · 2005 · 138 citations

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Devan V. Mehrotra, Holly Janes, Thomas R. Fleming et al. · Annals of Internal Medicine · 2020 · 114 citations · Full text

, , +11

Rows per page

1–5 of 25